A new platform for ultra-high dose rate radiobiological research using the BELLA PW laser proton beamline
Abstract Radiotherapy is the current standard of care for more than 50% of all cancer patients.Improvements in radiotherapy (RT) technology have increased tumor targeting and normal tissue sparing.Radiations at ultra-high dose rates required for FLASH-RT effects have sparked interest in potentially providing additional differential therapeutic bene